This one-day meeting on Therapeutics and Antimicrobial Resistance (AMR) , from the Microbiology Society, brings together researchers from industry and academia, clinicians, policymakers, patient advocates, and early career scientists to explore new perspectives, expand horizons and foster long term collaborations. The morning will feature invited talks from leaders from the biotechnology industry, publishing, policy, public engagement, and patient advocacy, alongside a panel discussion on future directions in AMR therapeutics.
The afternoon will be highly interactive, with structured networking sessions including a World Antimicrobial Awareness Week (WAAW) “sandpit” activity to generate creative ideas, promote networking and build awareness of and influence policy on the growing threat of AMR.
The meeting aims to strengthen cross-disciplinary connections, highlight opportunities for impact, and catalyse new initiatives in therapeutics research, outreach and practice to minimise the effects of AMR as a public health threat.
Keynote speakers:
- Colin Brown (UK Health Security Agency, UK)
- Carmen Coxon (Medicines & Healthcare products Regulatory Agency, UK)
- Peter Jackson (BEAM Alliance & Infex Therapeutics, UK)
LabMed members get the same discounted rates as Microbiology Society members.
Just use the discount code ALM20. There are also some fee-waived places for early career scientists and the details are on the website.
